HK1212625A1 - 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑 - Google Patents

用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑

Info

Publication number
HK1212625A1
HK1212625A1 HK16100660.1A HK16100660A HK1212625A1 HK 1212625 A1 HK1212625 A1 HK 1212625A1 HK 16100660 A HK16100660 A HK 16100660A HK 1212625 A1 HK1212625 A1 HK 1212625A1
Authority
HK
Hong Kong
Prior art keywords
cxcl11
cxcl13
cxcl9
cxcr5
cxcl10
Prior art date
Application number
HK16100660.1A
Other languages
English (en)
Inventor
‧利拉德 詹姆斯‧
Original Assignee
Jyant Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jyant Tech filed Critical Jyant Tech
Publication of HK1212625A1 publication Critical patent/HK1212625A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16100660.1A 2012-06-27 2016-01-21 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑 HK1212625A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/044475 WO2014003744A1 (en) 2012-06-27 2012-06-27 Anti-cxcl9, anti-cxcl 10, anti-cxcl 11, anti-cxcl 13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder

Publications (1)

Publication Number Publication Date
HK1212625A1 true HK1212625A1 (zh) 2016-06-17

Family

ID=49783686

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100660.1A HK1212625A1 (zh) 2012-06-27 2016-01-21 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑

Country Status (3)

Country Link
CN (2) CN104870012A (zh)
HK (1) HK1212625A1 (zh)
WO (1) WO2014003744A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015039126A1 (en) 2013-09-16 2015-03-19 Children hospital medical center Compositions and methods for treatment of hsct-associated thrombotic microangiopathy
EP3307318A4 (en) 2015-06-09 2019-01-16 Children's Hospital Medical Center DOSAGE ALGORITHM FOR COMPLEMENT INHIBITOR
CN105505941A (zh) * 2016-01-21 2016-04-20 中国人民解放军第四军医大学 Cxcl1的适配体在制备检测上尿路上皮癌试剂中的应用
CN106119348B (zh) * 2016-06-27 2018-02-23 中南大学湘雅医院 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用
CN106755356A (zh) * 2016-12-05 2017-05-31 深圳市第二人民医院 用于检测关节炎的标志物、基因芯片以及制备方法
CN107236023B (zh) * 2017-05-12 2021-05-07 苏州创澜生物科技有限公司 一种用于检测结核感染的抗原组合物及其应用
CN111183360A (zh) * 2017-07-19 2020-05-19 生物辐射欧洲有限公司 同时评估非酒精性脂肪性肝炎和肝纤维化状态的生物标志物组合
CN107656067B (zh) * 2017-09-18 2019-11-15 上海交通大学医学院附属上海儿童医学中心 一种评估sle患儿总体疾病活动度和肾脏疾病活动度的检测方法及其应用
EP3717004A4 (en) * 2017-12-01 2021-12-01 Children's Hospital Medical Center COMPOSITIONS FOR BLOCKING INTERERONS AND THEIR METHODS OF USE
US11891439B2 (en) 2017-12-28 2024-02-06 Astute Medical, Inc. Antibodies and assays for CCL14
CA3099275A1 (en) * 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
CN110251669B (zh) * 2019-06-18 2023-05-19 中山大学附属第六医院 Cxcl16蛋白及其单克隆抗体在制备预防和/或治疗肠道损伤性疾病的药物中的应用
CN110607362A (zh) * 2019-10-12 2019-12-24 南通大学 用于慢性疼痛疾病的生物诊断标记物及cxcl10在制备慢性疼痛药物中的应用
WO2023213400A1 (en) * 2022-05-05 2023-11-09 Institute For Research In Biomedicine Antibodies against chemokines, method for identifying said antibodies and uses thereof
CN118112257A (zh) * 2024-03-12 2024-05-31 山东中鸿特检生物科技有限公司 一种系统性红斑狼疮的检测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294290A1 (en) * 2002-11-15 2004-06-15 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
WO2007046087A2 (en) * 2005-10-16 2007-04-26 Yeda Research And Development Co.Ltd. Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions
WO2007091254A1 (en) * 2006-02-06 2007-08-16 Rappaport Family Institute For Research In The Medical Sciences Methods and kit for diagnosing t1dm
US20080199481A1 (en) * 2007-02-21 2008-08-21 Astrazeneca Ab Compounds
KR101583487B1 (ko) * 2007-06-05 2016-01-08 사노피 치환된 벤조일아미노-인단-2-카복실산 및 관련된 화합물
KR101701140B1 (ko) * 2007-08-29 2017-02-01 사노피 인간화된 항-ｃｘｃｒ5 항체, 이의 유도체 및 이들의 용도
CA2703333A1 (en) * 2007-10-26 2009-04-30 Galderma Research & Development Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof
CN101833001B (zh) * 2010-04-21 2013-08-28 广州瑞博奥生物科技有限公司 一种检测炎症因子的蛋白质芯片试剂盒及其制备方法
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS

Also Published As

Publication number Publication date
WO2014003744A1 (en) 2014-01-03
CN107478843A (zh) 2017-12-15
CN104870012A (zh) 2015-08-26

Similar Documents

Publication Publication Date Title
HK1212625A1 (zh) 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑
HK1216009A1 (zh) 前列環素組合物及其使用方法
DK2922554T3 (en) Terminalt modificeret rna
GB2508204B (en) Orthosis
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
GB201304967D0 (en) .
GB201204183D0 (en) .
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
ZA201403090B (en) Tropicalizing agent
EP2823830A4 (en) MESH-HIGHNESS MEDIUM
EP2894311A4 (en) QUIET
EP2884064A4 (en) MUFFLER
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
LT2858606T (lt) Įtvaras
PL2838352T3 (pl) Wóz paszowy
ZA201409119B (en) Polymer-nsaid conjugate
EP2787050A4 (en) LECITHIN-Organogel formers
TWI562734B (en) Sense-improving agent
EP2764870A4 (en) MEANS FOR IMPROVED SENSUAL ASSESSMENT
SG11201406911RA (en) Hair-growing agent
GB201212457D0 (en) Smart-road-smart-smart-vehicle synergy
ZA201209168B (en) Descaling
GB201223358D0 (en) Combines
GB201223361D0 (en) Combines
AU344960S (en) Sideboard